Jubilant Pharmo

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE700A01033
NSEID: JUBLPHARMA
BSEID: 530019

INR

1,065.15

-2.1 (-0.2%)

BSENSE

Dec 26

BSE+NSE Vol: 14.09 k

{
  "main_header": {
    "sid": 525933,
    "name": "Jubilant Pharmo",
    "stock_name": "Jubilant Pharmo",
    "full_name": "Jubilant Pharmova Ltd",
    "name_url": "stocks-analysis/jubilant-pharmo",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,065.15",
    "chg": -2.1,
    "chgp": "-0.2%",
    "dir": -1,
    "prev_price": "1,067.25",
    "mcapval": "16,965.83 Cr",
    "mcap": "Small Cap",
    "scripcode": 530019,
    "symbol": "JUBLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE700A01033",
    "curr_date": "Dec 26",
    "curr_time": "",
    "bse_nse_vol": "14.09 k",
    "exc_status": "Active",
    "traded_date": "Dec 26, 2025",
    "traded_date_str": "2025 12 26",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jubilant-pharmo-525933-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jubilant Pharmova Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmovas-technical-momentum-shifts-amid-mixed-indicator-signals-3766372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_technicaldot_3766372.png",
        "date": "2025-12-23 08:07:42",
        "description": "Jubilant Pharmova’s stock price momentum has exhibited a subtle shift from a sideways trend to a mildly bullish stance, reflecting nuanced changes in key technical indicators. Despite some bearish signals on longer-term charts, daily moving averages suggest a cautiously optimistic outlook for the pharmaceutical and biotechnology company as it navigates current market conditions."
      },
      {
        "title": "Jubilant Pharmova’s Market Assessment Reflects Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-downgraded-to-sell-amid-technical-and-financial-concerns-3765119",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_mojoScore_3765119.png",
        "date": "2025-12-22 08:02:51",
        "description": "Jubilant Pharmova’s recent market evaluation reveals a nuanced picture shaped by its financial performance, valuation metrics, and technical indicators. While the pharmaceutical company shows signs of valuation appeal, its financial trends and technical signals suggest a cautious outlook amid a challenging sector environment."
      },
      {
        "title": "Jubilant Pharmova Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-technical-momentum-shifts-amid-mixed-market-signals-3760688",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_technicaldot_3760688.png",
        "date": "2025-12-17 08:07:35",
        "description": "Jubilant Pharmova's stock price momentum has experienced a notable shift as recent technical indicators reveal a transition from a mildly bullish stance to a more sideways trend. This development comes amid a complex backdrop of mixed signals from key momentum and volume indicators, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Jubilant Pharmova’s Market Assessment Reflects Mixed Signals Amidst Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-upgraded-to-hold-as-technicals-improve-and-valuation-attracts-3759398",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_mojoScore_3759398.png",
        "date": "2025-12-16 08:09:36",
        "description": "Jubilant Pharmova’s recent market evaluation reveals a nuanced picture shaped by technical indicators, valuation metrics, financial trends, and broader sector performance. While the stock shows signs of mild technical optimism, its financial trajectory and valuation relative to peers present a complex scenario for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jubilant Pharmova Exhibits Shift in Price Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-shows-mildly-bullish-momentum-amid-mixed-technical-signals-3759387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_technicaldot_3759387.png",
        "date": "2025-12-16 08:09:14",
        "description": "Jubilant Pharmova's stock price has shown a subtle shift in momentum, moving from a sideways trend to a mildly bullish stance, as reflected in recent technical indicators. Despite mixed signals from key metrics such as MACD and RSI, the stock's daily moving averages suggest a cautiously optimistic outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jubilant Pharmova Shows Mixed Technical Signals Amid Sideways Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-technical-momentum-shifts-amid-mixed-market-signals-3757030",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_technicaldot_3757030.png",
        "date": "2025-12-12 08:04:41",
        "description": "Jubilant Pharmova’s recent price action reflects a nuanced shift in technical momentum, with key indicators signalling a transition from a mildly bearish stance to a more sideways trend. The stock’s performance over various timeframes reveals a complex interplay between short-term bullishness and longer-term caution within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jubilant Pharmova Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-faces-mildly-bearish-momentum-amid-technical-downgrade-3754660",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_technicaldot_3754660.png",
        "date": "2025-12-10 08:05:38",
        "description": "Jubilant Pharmova's stock has experienced a notable shift in technical momentum, moving from a sideways trend to a mildly bearish stance. This change is reflected across several key technical indicators, including the MACD, moving averages, and Bollinger Bands, signalling a nuanced market assessment for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Is Jubilant Pharmo technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jubilant-pharmo-technically-bullish-or-bearish-3745390",
        "imagepath": "",
        "date": "2025-12-04 08:29:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Shift and Current Price Action</strong></p>\n<p>As of 3 December 2025, Jubilant Pharmo's technical trend transitioned from mildly bullish to sideways, signalling a pause in directional momentum. The stock closed at ₹1,077.90, down from the previous close of ₹1,095.45, with intraday trading ranging between ₹1,071.40 and ₹1,098.20. This price action suggests a consolidation phase after recent volatility, with the stock currently trading below its 52-week high of ₹1,263.90 but comfortably above its 52-week low of ₹823.70.</p>\n<p><strong>Mixed Technical Indicators Paint a Complex Picture</strong></p>\n<p>Examining key technical indicators reveals a blend of bearish and mildly bullish signals. The Moving Average Convergence Divergence (MACD) on both weekly and monthly charts remains..."
      },
      {
        "title": "Jubilant Pharmova Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-faces-technical-setback-amid-mixed-momentum-signals-3745426",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/JubilantPharmov_technicaldot_3745426.png",
        "date": "2025-12-04 08:06:47",
        "description": "Jubilant Pharmova’s stock price has experienced a notable shift in momentum, reflecting a complex interplay of technical indicators that suggest a transition from a mildly bullish trend to a sideways movement. This development comes amid a backdrop of mixed signals from key technical parameters such as MACD, RSI, moving averages, and Bollinger Bands, highlighting the nuanced market assessment of the pharmaceutical and biotechnology firm."
      }
    ],
    "total": 362,
    "sid": "525933",
    "stock_news_url": "https://www.marketsmojo.com/news/jubilant-pharmova-525933"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of Adjudication Order_GST",
      "datetime": "05-Dec-2025",
      "details": "Receipt of Adjudication Order by Deputy Commissioner of Commercial Taxes",
      "source": "BSE"
    },
    {
      "caption": "Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares",
      "datetime": "02-Dec-2025",
      "details": "Report on Special Window for Re-lodgement of Transfer Requests of Physical Shares",
      "source": "BSE"
    },
    {
      "caption": "Appointment Of Mr. Daniel J. OConnor As CEO Of Jubilant Therapeutics Inc.",
      "datetime": "02-Dec-2025",
      "details": "Appointment of Mr. Daniel J. O Connor as CEO of Jubilant Therapeutics Inc.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06",
          "dt": "2006-03-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jubilant Pharmova Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-23 08:07:42

Jubilant Pharmova’s stock price momentum has exhibited a subtle shift from a sideways trend to a mildly bullish stance, reflecting nuanced changes in key technical indicators. Despite some bearish signals on longer-term charts, daily moving averages suggest a cautiously optimistic outlook for the pharmaceutical and biotechnology company as it navigates current market conditions.

Jubilant Pharmova’s Market Assessment Reflects Mixed Financial and Technical Signals

2025-12-22 08:02:51

Jubilant Pharmova’s recent market evaluation reveals a nuanced picture shaped by its financial performance, valuation metrics, and technical indicators. While the pharmaceutical company shows signs of valuation appeal, its financial trends and technical signals suggest a cautious outlook amid a challenging sector environment.

Jubilant Pharmova Technical Momentum Shifts Amid Mixed Market Signals

2025-12-17 08:07:35

Jubilant Pharmova's stock price momentum has experienced a notable shift as recent technical indicators reveal a transition from a mildly bullish stance to a more sideways trend. This development comes amid a complex backdrop of mixed signals from key momentum and volume indicators, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company.

Jubilant Pharmova’s Market Assessment Reflects Mixed Signals Amidst Sector Dynamics

2025-12-16 08:09:36

Jubilant Pharmova’s recent market evaluation reveals a nuanced picture shaped by technical indicators, valuation metrics, financial trends, and broader sector performance. While the stock shows signs of mild technical optimism, its financial trajectory and valuation relative to peers present a complex scenario for investors navigating the Pharmaceuticals & Biotechnology sector.

Jubilant Pharmova Exhibits Shift in Price Momentum Amid Mixed Technical Signals

2025-12-16 08:09:14

Jubilant Pharmova's stock price has shown a subtle shift in momentum, moving from a sideways trend to a mildly bullish stance, as reflected in recent technical indicators. Despite mixed signals from key metrics such as MACD and RSI, the stock's daily moving averages suggest a cautiously optimistic outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Jubilant Pharmova Shows Mixed Technical Signals Amid Sideways Momentum

2025-12-12 08:04:41

Jubilant Pharmova’s recent price action reflects a nuanced shift in technical momentum, with key indicators signalling a transition from a mildly bearish stance to a more sideways trend. The stock’s performance over various timeframes reveals a complex interplay between short-term bullishness and longer-term caution within the Pharmaceuticals & Biotechnology sector.

Jubilant Pharmova Technical Momentum Shifts Amid Mixed Market Signals

2025-12-10 08:05:38

Jubilant Pharmova's stock has experienced a notable shift in technical momentum, moving from a sideways trend to a mildly bearish stance. This change is reflected across several key technical indicators, including the MACD, moving averages, and Bollinger Bands, signalling a nuanced market assessment for the pharmaceutical and biotechnology company.

Is Jubilant Pharmo technically bullish or bearish?

2025-12-04 08:29:15

Technical Trend Shift and Current Price Action

As of 3 December 2025, Jubilant Pharmo's technical trend transitioned from mildly bullish to sideways, signalling a pause in directional momentum. The stock closed at ₹1,077.90, down from the previous close of ₹1,095.45, with intraday trading ranging between ₹1,071.40 and ₹1,098.20. This price action suggests a consolidation phase after recent volatility, with the stock currently trading below its 52-week high of ₹1,263.90 but comfortably above its 52-week low of ₹823.70.

Mixed Technical Indicators Paint a Complex Picture

Examining key technical indicators reveals a blend of bearish and mildly bullish signals. The Moving Average Convergence Divergence (MACD) on both weekly and monthly charts remains...

Jubilant Pharmova Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:06:47

Jubilant Pharmova’s stock price has experienced a notable shift in momentum, reflecting a complex interplay of technical indicators that suggest a transition from a mildly bullish trend to a sideways movement. This development comes amid a backdrop of mixed signals from key technical parameters such as MACD, RSI, moving averages, and Bollinger Bands, highlighting the nuanced market assessment of the pharmaceutical and biotechnology firm.